Peter Jennings, DPM
Podiatrist · Dillon, MTNPI 1740852276
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.9%), food and beverage and other — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Arthrex at 55.5% of the total. Reporting peaked in 2024 at $2,544 and has fallen 82.2% since, to $454 in 2025.
Across 44 payments — averaging $68.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Forthright Medical - MT, LLC$404
- Sioux Surgical Inc$343
- Integra Lifesciences Corporation$129
- Convatec Inc.$129
- Nevro Corp.$100
- plus $239 from 7 others
What the payments were for
- Travel & lodging$1,65955%
- Food & beverage$1,23341%
- Other$1294%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 19 | $1,677 |
| Forthright Medical - MT, LLC | 7 | $404 |
| Sioux Surgical Inc | 7 | $343 |
| Integra Lifesciences Corporation | 2 | $129 |
| Convatec Inc. | 1 | $129 |
| Nevro Corp. | 1 | $100 |
| Acumed LLC | 1 | $57 |
| Paratek Pharmaceuticals, Inc. | 1 | $50 |
| Stryker | 1 | $49 |
| Polynovo North America LLC | 1 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Mimedx Group, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RELJA Reduction Clamp$189
- InnovaMatrix AC$129
How this compares
Too few podiatrist providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 24 | $163 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Dillon
- Shawn BraunagelBillings$34K
- Trent LottLewistown$8K
- Kevin KundisGreat Falls$4K
- David EkmanBillings$4K
- Katie Kovacich SmithFort Harrision$3K
- James CloughPolson$2K
- Anthony QuebedeauxHelena$224
- Philip SchrumpfMissoula$172
- Justin HookerShelby$34
- Bruce FisherGreat Falls$13
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.